The question every reader asks when looking at the SOJA3 chart is straightforward: if Boa Safra Sementes is the market leader and sells more with each harvest, why has the stock dropped roughly 67% from its 2023 peak of over R$ 18 to below R$ 6? The answer is just as straightforward — selling more stopped meaning earning more. In 2025, the company reached record revenue of R$ 2.62 billion (+42%) and record volume of 215,000 big bags (+34%), but net income attributable to controlling shareholders (the portion of earnings that actually belongs to SOJA3 investors, after deducting minority partners in funds and affiliates) plummeted from R$ 301.5 million in 2023 to R$ 20.0 million in 2025.
What broke wasn't demand: it was profitability. The adjusted EBITDA margin — which measures how much revenue remains after expenses, tracking pure operational efficiency — dropped from 10% to 5.9%. Below the operational line, debt interest expenses exploded by 254% (reaching R$ 132 million in 2025) after the company issued roughly R$ 1 billion in CRAs (Agribusiness Receivables Certificates, debt instruments sold to raise capital) at a cost of the CDI rate plus 3% per year, with the Selic benchmark rate running high. The stock fell because earnings fell — and fell much faster than revenue rose.
What Is Boa Safra, Explained from Scratch
Before planting soybeans, farmers need to buy seeds. Boa Safra is the largest independent seller of these seeds in Brazil: out of every 10 bags of certified soybean seeds sold in the country, one belongs to the company — representing a record 10% market share. The company does not plant crops to harvest grain. Instead, it contracts about 320,000 hectares from partner farmers to multiply seeds, processes this material in its own facilities (with a capacity of 280,000 big bags per year), and distributes it to 996 distributors across Brazil. Founded by the Colpo family in Formosa, Goiás, the company went public on the B3 in April 2021 on the Novo Mercado listing segment.
One characteristic of this business changes everything when reading financial results: seasonality is brutal. Roughly 89% of revenue is generated in the second half of the year, because seeds are delivered close to planting season (September through December). The first quarter is dedicated to inventory building — the company burns cash, net debt peaks, and quarterly EBITDA can even turn negative. This is completely normal.
Never annualize Boa Safra's first-quarter results. Net debt jumped from R$ 151 million in December 2025 to R$ 848 million in March 2026. This is not a sign of deterioration, but rather the seasonal cycle of purchasing grain to build inventory. What matters is the full-year closing figures and comparisons against the same quarter of the previous year.
Anatomy of a Drop: Three Blows at Once
The financial history tells the whole story. Revenue grows, but profitability collapses — and every line in the table below hides a specific cause.
| Period | Net Rev. (R$ mil.) | Gross Margin | Adj. EBITDA Margin | Control. Net Inc. (R$ mil.) | Big Bags (thous.) |
|---|---|---|---|---|---|
| 2023 | 2,079 | 14.8% | — | 301.5 | 164 |
| 2024 | 1,841 | 13.1% | 10.0% | 93.5 | 161 |
| 2025 | 2,622 | 10.3% | 5.9% | 20.0 | 215 |
| Q1 26 (qtr.) | 132 | 21% | n/a (seasonal) | 3.7 (ex-SNAG11) | — |
| 12m ending Mar/26 | 2,591 | — | 5.1% | 15.2 (ex-SNAG11) | — |
The first blow came from pricing. The entire sector overproduced seeds — creating a structural surplus of about 30% — and excess supply drove selling prices down. Add in higher grain acquisition costs and an above-average quality discard rate (15% versus a historical 10% due to irregular weather), and gross margin sank from 14.8% to 10.3%. EBITDA per big bag, which measures how much the company earns per unit sold, plummeted from roughly R$ 1,900 in 2023 to R$ 1,100 in 2025.
The second blow landed below the operational line: R$ 132 million in interest expenses (+254%) on approximately R$ 1 billion in CRAs yielding CDI + 3%. This figure equals nearly 7 times the company's annual net income attributable to controllers. Expensive debt, taken on to finance growth, now consumes nearly everything the core operation generates.
The third blow came from customers. Brazil's agricultural sector is experiencing its worst credit crunch in historical series: 1,990 judicial reorganizations in agribusiness in 2025 (+56%), with rural credit default rates rising from 1.2% to 3.3%. Capital-constrained farmers do two things that hurt Boa Safra simultaneously: they delay purchases and resort to saved seeds — seeds kept from their own previous harvest and replanted without paying for certified stock. Today, 27% of the country's soybean acreage already uses uncertified seeds, representing a permanent competitive ceiling for the business.
Watch out for the consolidated accounting trap. Consolidated net income for 2025 appears as R$ 101 million in some sources — but this is an accounting illusion. Roughly R$ 81 million of that total belonged to minority investors in the SNAG11 fund, which the company sold in early 2026. The figure that matters for SOJA3 investors is the net income attributed to controlling shareholders: R$ 20.0 million. Always use that number.
So Why Is There Still a Buy Thesis?
Because the market values the company at less than its paper net worth. The P/B ratio (Price-to-Book value — how much the stock costs relative to equity per share) sits at 0.63x, with book value at R$ 9.59 per share. In short, the market values all of Boa Safra at R$ 853 million, despite being a leading operation with R$ 2.6 billion in revenue that has already cleared SNAG11 from its balance sheet.
Turnaround levers are visible: the order backlog hit a record R$ 1.5 billion in Q1 2026 — an unusual feat for a first quarter that provides rare visibility for second-half deliveries. Soybean prices in Chicago have rebounded (US$ 12.26 per bushel), the Selic rate has started to decline (currently at 14.25%, with projections reaching 12.5% by year-end 2026 — every 1-percentage-point cut provides R$ 10 million to R$ 13 million in annual interest relief), and the company is repurchasing up to 4.95% of its free float, signaling that management itself considers the stock cheap.
There is also an underlying structural catalyst: Bill PL 1702/19, which proposes a royalty on saved seeds. If it advances through Congress, it would alter the sector's economics — every real collected on pirated seeds pushes acreage back into the formal market, exactly where Boa Safra is the leader. However, this depends on Congress and has no defined timeline.
What Is It Actually Worth? Valuation with Assumptions on the Table
SOJA3 is a classic case where each multiple tells a different story. Based on today's depressed earnings, the stock looks expensive (P/E of roughly 35x). Based on book value, it looks very cheap (0.63x). The solution is to estimate mid-cycle earnings — neither the 2023 peak nor the 2025 trough — and cross-reference three independent methods.
| Method | Fair Price | Core Assumption |
|---|---|---|
| P/B × Normalized Return | R$ 7.40 | Book value of R$ 9.59/share, ROE normalizing at 7-9%, fair P/B of 0.75-0.80x |
| Normalized Earnings × P/E | R$ 6.70 | Net margin of 4% on R$ 2.6 bil. = ~R$ 105 mil. in earnings at a 9x P/E |
| Normalized EV/EBITDA | R$ 6.20 | EBITDA of ~R$ 220 mil. (8.5% margin) × 6x, minus average net debt |
| Reference: Wall Street Consensus | R$ 6.50 to R$ 12 | Citi R$ 6.50 · Bradesco R$ 9 · Itaú R$ 10 · XP R$ 11.80 · BTG R$ 12 (sanity check only) |
Our three proprietary methods converge on a range of R$ 6.20 to R$ 7.40, with a midpoint at R$ 7.00 — representing +17% upside over the current R$ 5.97, which is insufficient to compensate for risk without margin confirmation signals. The full fair value range runs from R$ 5.00 (floor) to R$ 10.00 (ceiling). At R$ 5.97, the market nearly prices in a pessimistic scenario; purchases below R$ 5.50 incorporate a real margin of safety even under the base case, whereas above R$ 7.00 investors are paying for a recovery before it actually materializes.
Three Scenarios, Three Observable Triggers
| Scenario | Target Price | Probability | What Needs to Happen |
|---|---|---|---|
| Optimistic — Cycle Turnaround | R$ 10.00 | ~25% | EBITDA margin returning to 8-10% in H2 2026, soybeans above US$ 12.50, Selic at 12%, PL 1702/19 advancing |
| Base — Slow Recovery | R$ 7.00 | ~50% | Order backlog converted with pricing still pressured, partial margin of 7-8%, normal seasonal deleveraging |
| Pessimistic — Squeeze Becomes Crisis | R$ 4.80 | ~25% | Rural credit worsening, seed surplus persisting, debt covenants breached, Selic rate cuts halting |
In the pessimistic scenario, an overlooked warning applies: the asset discount stops acting as a floor. A seed producer's asset base consists of inventory and receivables from stressed farmers — during liquidation, these are worth less than the balance sheet suggests. Cyclical small caps often break through rational floors during moments of panic.
Dividends: Not an Income Stock
Do not count on meaningful dividends from SOJA3. The company lacks a formal payout policy and directs earnings to its "Expansion Reserve" — the April 2026 annual meeting retained R$ 19 million out of R$ 20 million in earnings. The R$ 40 million in Interest on Equity (IOE) paid in December 2025 actually exceeded the year's earnings — a gesture that consumed reserves and cannot be repeated without a earnings recovery. A contractual clause even restricts distributions if group defaults rise. If any returns come from this stock, they will come from capital appreciation, not income.
The Thesis Test: November 2026
All the discussion above hinges on one observable variable. The ultimate test is the Q3 2026 earnings report, released in November 2026, when roughly 44% of annual revenue flows through the results. The trigger is clear-cut:
An adjusted Q3 2026 EBITDA margin ≥ 8% confirms the recovery thesis. Anything below 6% invalidates it — signaling that the problem is structural rather than cyclical, and the stock would lose its valuation argument.
Aside from margins, investors should monitor: net debt in September and December (seasonal patterns dictate it should plummet in the second half — if it fails to drop, it's a red flag), agricultural default rates and the company's provision for doubtful accounts (which jumped from R$ 0.6 million to R$ 13 million, with a healthy limit below 3% of receivables), Chicago soybean prices, and the progress of bill PL 1702/19.
In short: SOJA3 is a wager that the agricultural cycle turned before the numbers proved it — cheap on book value, expensive on current earnings, suitable for a small position, a patient mindset, and a close eye on November results. Existing holders find reasons to hold in the record backlog and improving macroeconomic picture. Investors on the sidelines can wait for margin confirmation in Q3 2026, paying perhaps 15-20% more in exchange for substantially less risk.
Verdict: UNDER REVIEW — score 5.5/10. Boa Safra is a legitimate, market-leading business, but it is navigating a leveraged turnaround amid a rural credit crisis. Estimated fair value sits at R$ 7.00 (range of R$ 5.00 to R$ 10.00). This is not an investment recommendation; the final decision is yours.
This text summarizes the complete analysis. The detailed dossier — covering fundamentals, risks, governance, scenarios, and valuation — is available at /acoes/soja3/ (Analysis tab). You can also access the PDF report, produced by the site with artificial intelligence assistance — it is not an official document from Boa Safra Sementes S.A.
